Coeptis Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Coeptis Therapeutics, Inc. reported Earnings Per Share, Basic and Diluted of -$0.42 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-11
- Coeptis Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.08.
- Coeptis Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.17.
- Coeptis Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.09.
- Coeptis Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.07.
- Coeptis Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2021 was -$0.42.
- Coeptis Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$0.51.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 4 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 7 month | Earnings Per Share, Basic and Diluted 8 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 10 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2022-03-11 | -$0.25 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$0.34 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$0.42 10-K · filed 2022-03-11 | ||||
| 2021-09-30 | -$0.17 10-Q · filed 2021-11-15 | -$0.27 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$0.34 10-Q · filed 2021-11-15 | -$0.56 derived: net income ÷ weighted average shares · filed 2022-11-08 | ||||
| 2021-06-30 | -$0.09 10-Q · filed 2021-08-16 | -$0.16 10-Q · filed 2021-08-16 | -$0.38 derived: net income ÷ weighted average shares · filed 2022-11-08 | |||||
| 2021-03-31 | -$0.07 10-Q/A · filed 2021-05-18 | -$0.30 derived: net income ÷ weighted average shares · filed 2022-11-08 | ||||||
| 2020-12-31 | -$0.30 derived: net income ÷ weighted average shares · filed 2022-03-11 | -$0.36 10-KT · filed 2021-05-11 | -$0.51 10-K · filed 2022-03-11 | |||||
| 2020-11-30 | -$0.30 10-Q · filed 2021-01-11 | -$0.32 10-Q · filed 2021-01-11 | ||||||
| 2020-09-30 | -$0.09 10-Q · filed 2021-11-15 | -$0.23 10-Q · filed 2021-11-15 | ||||||
| 2020-08-31 | $0.00 10-Q/A · filed 2020-11-23 | $0.00 10-Q/A · filed 2020-11-23 | ||||||
| 2020-06-30 | -$0.04 10-Q · filed 2021-08-16 | -$0.14 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | -$0.12 10-Q/A · filed 2021-05-18 | |||||||
| 2019-12-31 | $0.00 10-KT · filed 2021-05-11 | |||||||
| 2019-11-30 | $0.00 10-Q · filed 2021-01-11 | $0.00 derived: net income ÷ weighted average shares · filed 2021-01-11 | $0.00 10-Q · filed 2021-01-11 | |||||
| 2019-08-31 | $0.00 10-Q/A · filed 2020-11-23 | $0.00 10-Q/A · filed 2020-11-23 |